Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in major trauma patients in intensive care
ISRCTN40935649Phase 4Terminated
- Sponsor
- Swansea Bay University Health Board
- Start
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised trial in Major trauma comparing rhEPO with Placebo (2 arms). Primary endpoint: Multiple organ failure. Started Oct 2016; status: terminated.
02
Drugs
erythropoietin
03
Conditions
Major trauma
Beyond the preview
Go deeper on ISRCTN40935649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN40935649.